This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Brokers Suggest Investing in Synchronoss (SNCR): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Synchronoss (SNCR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SNCRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Ares Capital (ARCC) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ARCCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Reddit Inc. (RDDT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Reddit Inc. (RDDT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RDDTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in AZZ (AZZ) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AZZ (AZZ) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AZZPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Nvidia (NVDA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nvidia (NVDA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NVDANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Netflix (NFLX) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Netflix (NFLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NFLXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Royal Caribbean (RCL): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Royal Caribbean (RCL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
RCLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is BRF (BRFS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), BRF (BRFS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BRFSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Energy Fuels (UUUU) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Energy Fuels (UUUU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UUUUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Ero Copper (ERO): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ero Copper (ERO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ERONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Monday.com (MNDY) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Monday.com (MNDY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MNDYPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Merck (MRK) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MRKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ADMAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Rocket Lab USA (RKLB) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Rocket Lab USA (RKLB) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
RKLBNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Roblox (RBLX): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Roblox (RBLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
RBLXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Halliburton (HAL): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Halliburton (HAL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HALPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Dynatrace (DT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Dynatrace (DT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Ross Stores (ROST): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ross Stores (ROST). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ROSTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
M/I Homes (MHO) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in M/I Homes (MHO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MHOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About PDD Holdings Inc. Sponsored ADR (PDD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PDD Holdings Inc. Sponsored ADR (PDD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PDDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Bit Digital (BTBT): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Bit Digital (BTBT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BTBTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About XPeng (XPEV): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), XPeng (XPEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
XPEVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in OneSpan (OSPN) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for OneSpan (OSPN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
OSPNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Silicon Motion (SIMO) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Silicon Motion (SIMO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SIMONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Kyndryl Holdings, Inc. (KD): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Kyndryl Holdings, Inc. (KD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
KDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth